CHC Group Ltd (HELI) is Trading Higher on Unusual Volume for December 21

Equities Staff  |

CHC Group Ltd (HELI) experienced unusually high volume on Dec. 21, as the stock gained 20.76% to a closing price of $6.05. The stock saw 105,779 shares trade hands over the course of the day on 586 trades. Given that the stock’s average daily volume over the last month has been 38,673 shares a day, this represents a pretty substantial spike over the norm.

CHC Group Ltd has a P/B ratio of -0.01. The stock has traded between $119.10 and $3.74 over the last 52-weeks, its 50-day SMA is now $9.68, and its 200-day SMA $24.86.

CHC Group Ltd is a commercial helicopter service provider to the offshore oil and gas industry. It is a commercial operator of heavy and medium helicopter based on its fleet of approximately 231 heavy and medium helicopters.

Headquartered in Grand Cayman, , CHC Group Ltd has 4,400 employees and is currently under the leadership of CEO Karl Fessenden.

For a complete fundamental analysis analysis of CHC Group Ltd, check out’s Stock Valuation Analysis report for HELI. To see the latest independent stock recommendations from’s analysts, visit our Research section.


The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.

With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:



Symbol Last Price Change % Change










Level Headed at World Crypto Con - Steve Beauregard CRO Steve Beauregard joins Jack Brewer at World Crypto Con.

Emerging Growth

Q BioMed Inc

Q BioMed Inc is a biomedical acceleration and development company. The company is a biomedical acceleration and development company focused on licensing, acquiring and providing strategic resources to life sciences…